A deep science foray into LSD’s impact on the endocannabinoid system and the microbiome.
Is microdosing psychedelics a fad? A placebo? A panacea?
Scientists are studying psilocybin and LSD to treat migraines and cluster headaches.
Scientists are studying the therapeutic potential of psilocybin, the magic mushroom compound, for severe phantom limb pain.
Psychedelic treatments for OCD may yield insights into whether therapeutic benefits are caused by the drug alone, acting physiologically on the brain, or are they caused by the lived, subjective response engendered by the drug?
The pandemic isn’t stopping psychedelic advocacy.
Although it may not be obvious during these Trump-rattled times, we’re in the midst of a psychedelic revival. There is more interest than ever before in experimenting with LSD, magic mushrooms, ayahuasca, ketamine, and other psychedelic drugs.